Systematic review / meta-analysis / 2012
Omega-3 supplements showed no secondary preventive effect against major cardiovascular events.
A meta-analysis examined 14 double-blind randomized trials enrolling 20,485 individuals with prior cardiovascular conditions. Supplementation with eicosapentaenoic acid and docosahexaenoic acid did not lower overall cardiovascular event risk (RR 0.99; 95% CI, 0.89 to 1.09), heart attacks, strokes, or total mortality. An initial modest reduction in fatal cardiovascular events (RR 0.91; 95% CI, 0.84 to 0.99) disappeared after excluding one trial that had major methodological limitations.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 20,485 patients with preexisting cardiovascular disease across 14 trials
- What was measured
- cardiovascular events and mortality
THE PAPER
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Kwak SM, Myung SK, Lee YJ, Seo HG, Korean Meta-analysis Study Group. Arch Intern Med, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.